Cargando…

European Society for Medical Oncology (ESMO) 2018 Congress Twitter analysis: from ethics to results through the understanding of communication and interaction flows

BACKGROUND: Twitter is a microblogging service providing a platform for social networking. For medical information, Twitter is an interesting channel for sharing and spreading information and as an engagement platform for different stakeholders. Benefits and caveats of uncontrolled medical informati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Passaro, Antonio, Mackenzie, Graham, Lambertini, Matteo, Morgan, Gilberto, Zimmermann, Stefan, Garrido, Pilar, Curigliano, Giuseppe, Trapani, Dario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046424/ https://www.ncbi.nlm.nih.gov/pubmed/32133983 http://dx.doi.org/10.1136/esmoopen-2019-000598

Ejemplares similares

Correction: European society for medical oncology (ESMO) 2018 Congress Twitter analysis: from ethics to results through the understanding of communication and interaction flows
Publicado: (2020)

Career opportunities and benefits for young oncologists in the European Society for Medical Oncology (ESMO)
por: Morgan, Gilberto, et al.
Publicado: (2016)

From the ESMO Congress 2021
por: Sidaway, Peter
Publicado: (2021)

The impact of COVID-19 on oncology professionals: results of the ESMO Resilience Task Force survey collaboration
por: Banerjee, S., et al.
Publicado: (2021)

ESMO Open: news in breast cancer 2019
por: Lambertini, Matteo
Publicado: (2020)

Nachwuchsförderung durch die European Society for Medical Oncology (ESMO): Erfahrungen aus dem ESMO Young Oncologist Committee (YOC)
por: Oing, Christoph, et al.
Publicado: (2020)

Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring
por: Gyawali, B., et al.
Publicado: (2021)

Impact of COVID-19 on social media as perceived by the oncology community: results from a survey in collaboration with the European Society for Medical Oncology (ESMO) and the OncoAlert Network
por: Morgan, G., et al.
Publicado: (2021)

PB2707: ESMO-MAGNITUDE OF CLINICAL BENEFIT SCALE FOR HAEMATOLOGICAL MALIGNANCIES (ESMO-MCBS:H) VERSION 1.0
por: Kiesewetter, Barbara, et al.
Publicado: (2023)

Colorectal cancer: new developments after the 2013 ECCO/ESMO congress
por: Mellas, Nawfel, et al.
Publicado: (2014)

The concerns of oncology professionals during the COVID-19 pandemic: results from the ESMO Resilience Task Force survey II
por: Lim, K.H.J., et al.
Publicado: (2021)

Gender-related challenges facing oncologists: the results of the ESMO Women for Oncology Committee survey
por: Banerjee, Susana, et al.
Publicado: (2018)

ESMO Open—Cancer Horizons and the future of oncology
por: Zielinski, Christoph C
Publicado: (2016)

ESMO Leaders Generation Programme: an alumni insight
por: Arruda, Leticia De Mattos, et al.
Publicado: (2018)

ESMO Open special series on new emerging targets in cancer immunotherapy
por: Lambertini, Matteo
Publicado: (2020)

1561O The future of the oncology workforce since COVID-19: Results of the ESMO Resilience Task Force survey series
por: Lim, K.H.J., et al.
Publicado: (2021)

The impact of COVID-19 on oncology professionals—one year on: lessons learned from the ESMO Resilience Task Force survey series
por: Lim, K.H.J., et al.
Publicado: (2021)

LBA70_PR The impact of COVID-19 on oncology professionals: Initial results of the ESMO resilience task force survey collaboration
por: Banerjee, S., et al.
Publicado: (2020)

From precision medicine to cancer care through the immunome: highlights from the European Society of Medical Oncology Congress, Madrid, 26–30th September 2014
por: Curigliano, Giuseppe
Publicado: (2014)

The experience on coronavirus disease 2019 and cancer from an oncology hub institution in Milan, Lombardy Region
por: Trapani, Dario, et al.
Publicado: (2020)

ESMO Designated Centres of Integrated Oncology and Palliative Care (ESMO DCs): education, research and programme development survey
por: Kreye, G., et al.
Publicado: (2022)

ESMO Congress 2021: highlights from the EORTC gastrointestinal tract cancer group’s perspective
por: Koessler, T., et al.
Publicado: (2022)

Biomarkers come of age: PD1 in the frontline and cell cycle therapy swells the ranks of personalised therapy in the European Society of Medical Oncology (ESMO) congress, Copenhagen, 7–10 October 2016
por: Davies, Will
Publicado: (2016)

ESMO Clinical Practice Guidelines: adapting and adopting new approaches for development, implementation and audit
por: Pentheroudakis, G., et al.
Publicado: (2022)

Highlights of thoracic oncology from the 2018 ERS International Congress
por: Ntontsi, Polyxeni, et al.
Publicado: (2019)

Announcing the ESMO Open special issue on upcoming molecular targets for cancer treatment
por: Morgan, Gilberto, et al.
Publicado: (2020)

Nursing highlights from the 2015 European Cancer Congress (ECCO18–ESMO40), 25–29 September 2015, Vienna: reinforcing multidisciplinarity
por: Caruso, Rosario, et al.
Publicado: (2015)

Twelve ESMO Congress 2022 breakthroughs: practicing oncologists’ perceptions and potential application on presented data
por: van Halteren, H.K., et al.
Publicado: (2023)

Challenges in oncology career: are we closing the gender gap? Results of the new ESMO Women for Oncology Committee survey
por: Linardou, H., et al.
Publicado: (2023)

Adolescents and young adults (AYA) with cancer: a position paper from the AYA Working Group of the European Society for Medical Oncology (ESMO) and the European Society for Paediatric Oncology (SIOPE)
por: Ferrari, A., et al.
Publicado: (2021)

The ESMO/ASCO Global Curriculum and the evolution of medical oncology training in Europe
por: Pavlidis, Nicholas, et al.
Publicado: (2016)

ESMO Open welcomes the association with the Japanese Society of Medical Oncology (JSMO)
por: Ohe, Yuichiro, et al.
Publicado: (2017)

Indicators of integration at ESMO Designated Centres of Integrated Oncology and Palliative Care
por: Hui, David, et al.
Publicado: (2018)

Conference Report: European Society for Medical Oncology Congress 2022
por: Dogan, Sevda
Publicado: (2023)

ESMO20 YO for YO: highlights on new drugs in advanced breast cancer focusing on sacituzumab govitecan and alpelisib
por: Lambertini, M., et al.
Publicado: (2020)

Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus
por: Curigliano, G., et al.
Publicado: (2020)

ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016
por: Dittrich, Christian, et al.
Publicado: (2016)

The ESMO position paper on biosimilars in oncology: enhancing the provision of accurate education and information
por: Schiestl, Martin, et al.
Publicado: (2017)

ESMO/ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2023
por: Cufer, Tanja, et al.
Publicado: (2023)

Highlights and future directions from the European Gynecological Oncology Congress 2017
por: Selçuk, İlker
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9tettjnr45plu88aciql3fmtsa